Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -26.72 is 59% below its 4-year average of -16.78, near the low end of its 4-year range (-37.20–38.10).
26.24% above its 12-month average of -36.23.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): -1.46.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 31 comparable quarters.
FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T16:01:52.242Z. Historical observations retain their original dates. Historical series through 2023-03-16.
EARNINGS PER SHARE (EPS)
-26.72
EARNINGS PER SHARE (EPS) AVG TTM
-36.23
EARNINGS PER SHARE (EPS) AVG 3Y
-30.51
EARNINGS PER SHARE (EPS) AVG 5Y
-16.78
EARNINGS PER SHARE (EPS) AVG 10Y
-13.94
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
+26.24%
CURRENT VS 3Y AVG
+12.41%
CURRENT VS 5Y AVG
-59.20%
CURRENT VS 10Y AVG
-91.66%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Co-Diagnostics, Inc.
Market Cap
$6.75M
Earnings Per Share (EPS)
-26.72
TTM Avg
-36.23
3Y Avg
-30.51
5Y Avg
-16.78
Market Cap
$6.66M
Earnings Per Share (EPS)
-7.60
TTM Avg
-3746.91
3Y Avg
-66167.96
5Y Avg
-82548.30
Market Cap
$6.98M
Earnings Per Share (EPS)
-8.91
TTM Avg
-9.90
3Y Avg
-14.45
5Y Avg
-12.10
Market Cap
$6.98M
Earnings Per Share (EPS)
-1.16
TTM Avg
-3.29
3Y Avg
-3.69
5Y Avg
-2.95
Market Cap
$6.99M
Earnings Per Share (EPS)
-16.00
TTM Avg
-9.75
3Y Avg
-5.91
5Y Avg
-4.74
Market Cap
$6.50M
Earnings Per Share (EPS)
-16.46
TTM Avg
-132.36
3Y Avg
-129.45
5Y Avg
-404.68
Market Cap
$6.43M
Earnings Per Share (EPS)
-2.52
TTM Avg
-4.28
3Y Avg
-38.17
5Y Avg
-84.63
Market Cap
$7.16M
Earnings Per Share (EPS)
-81.82
TTM Avg
-336.50
3Y Avg
-753.63
5Y Avg
-537.05
Market Cap
$6.32M
Earnings Per Share (EPS)
-1.26
TTM Avg
-1.73
3Y Avg
-1.08
5Y Avg
-0.87
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Co-Diagnostics, Inc. (CODX) | $6.75M | -26.72 | -36.23 | -30.51 | -16.78 |
| Aclarion, Inc. (ACON)vs › | $6.66M | -7.60 | -3746.91 | -66167.96 | -82548.30 |
| NeuroSense Therapeutics Ltd. (NRSN)vs › | $6.98M | -8.91 | -9.90 | -14.45 | -12.10 |
| Mangoceuticals, Inc. (MGRX)vs › | $6.98M | -1.16 | -3.29 | -3.69 | -2.95 |
| Bolt Biotherapeutics, Inc. (BOLT)vs › | $6.99M | -16.00 | -9.75 | -5.91 | -4.74 |
| Enveric Biosciences, Inc. (ENVB)vs › | $6.50M | -16.46 | -132.36 | -129.45 | -404.68 |
| Ensysce Biosciences, Inc. (ENSC)vs › | $6.43M | -2.52 | -4.28 | -38.17 | -84.63 |
| KALA BIO, Inc. (KALA)vs › | $7.16M | -81.82 | -336.50 | -753.63 | -537.05 |
| Biomerica, Inc. (BMRA)vs › | $6.32M | -1.26 | -1.73 | -1.08 | -0.87 |
| Femasys Inc. (FEMY)vs › | $6.31M | -4.57 | -13.10 | -16.05 | -14.80 |
Trailing EPS (TTM)
$-26.72
Forward EPS (Est.)
$-3.10
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -35.25 |
| 2024-12-31 | -37.20 |
| 2023-12-31 | -36.00 |
| 2022-12-31 | -13.57 |
| 2021-12-31 | 38.10 |
| 2019-12-31 | -11.09 |
| 2018-12-31 | -15.00 |
| 2017-12-31 | -18.90 |
| 2016-12-31 | -5.10 |
| 2015-12-31 | -5.40 |
| 2014-12-31 | -3.90 |
